0001994145-26-000001.txt : 20260306 0001994145-26-000001.hdr.sgml : 20260306 20260306123259 ACCESSION NUMBER: 0001994145-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260306 DATE AS OF CHANGE: 20260306 EFFECTIVENESS DATE: 20260306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnZeta Immunotherapies, Inc. CENTRAL INDEX KEY: 0001994145 ORGANIZATION NAME: EIN: 932672754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-538757 FILM NUMBER: 26729625 BUSINESS ADDRESS: STREET 1: 122 SEVILLA AVE # 1814 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: 9173644613 MAIL ADDRESS: STREET 1: 122 SEVILLA AVE # 1814 CITY: CORAL GABLES STATE: FL ZIP: 33134 D/A 1 primary_doc.xml X0708 D/A LIVE 0001994145 EnZeta Immunotherapies, Inc. 122 SEVILLA AVE # 919 CORAL GABLES FL FLORIDA 33134 9173644613 DELAWARE None None Corporation true 2023 Paul Kelly 122 Sevilla Avenue, Suite 919 Coral Gables FL FLORIDA 33134 Executive Officer Director Sergio Traversa 650 NE 32nd Street, #3804 Miami FL FLORIDA 33137 Director Biotechnology Decline to Disclose 06b true 0001994145-25-000001 2025-02-17 true true true true false 0 2370000 840000 1530000 false 10 0 0 0 false EnZeta Immunotherapies, Inc. /s/ Paul Kelly Paul Kelly President 2026-03-06